Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gail M Wilkes

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Oncology (Williston Park, N.Y.)|October 29, 2009
New mTOR inhibitor for renal cell cancerGail M Wilkes
Asia-Pacific Journal of Oncology Nursing|April 3, 2018
Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted AgentsGail M Wilkes
Oncology (Williston Park, N.Y.)|February 1, 2011
Cabazitaxel, a taxane for men with hormone-refractory metastatic prostate cancerGail M Wilkes
Oncology (Williston Park, N.Y.)|October 28, 2009
Drug essentials mTOR inhibitorsGail M Wilkes
Oncology (Williston Park, N.Y.)|October 28, 2009
LevoleucovorinGail M Wilkes
Oncology (Williston Park, N.Y.)|November 7, 2014
Vismodegib, a hedgehog pathway inhibitor for adults with locally advanced or metastatic basal cell carcinomaGail M Wilkes
Oncology (Williston Park, N.Y.)|November 14, 2014
Denosumab, a rank ligand inhibitor for prevention of skeletal-related events due to bone metastases from solid tumors in adultsGail M Wilkes
Clinical Journal of Oncology Nursing|May 10, 2002
New therapeutic options in colon cancer: focus on oxaliplatinGail M Wilkes
Clinical Journal of Oncology Nursing|March 9, 2005
Therapeutic options in the management of colon cancer: 2005 updateGail M Wilkes
Oncology (Williston Park, N.Y.)|October 28, 2009
Drug essentials. Small molecule multitargeted TKI therapyGail M Wilkes
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Oncology (Williston Park, N.Y.)|October 29, 2009
New mTOR inhibitor for renal cell cancerGail M Wilkes
Asia-Pacific Journal of Oncology Nursing|April 3, 2018
Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted AgentsGail M Wilkes
Oncology (Williston Park, N.Y.)|February 1, 2011
Cabazitaxel, a taxane for men with hormone-refractory metastatic prostate cancerGail M Wilkes
Oncology (Williston Park, N.Y.)|October 28, 2009
Drug essentials mTOR inhibitorsGail M Wilkes
Oncology (Williston Park, N.Y.)|October 28, 2009
LevoleucovorinGail M Wilkes
Oncology (Williston Park, N.Y.)|November 7, 2014
Vismodegib, a hedgehog pathway inhibitor for adults with locally advanced or metastatic basal cell carcinomaGail M Wilkes
Oncology (Williston Park, N.Y.)|November 14, 2014
Denosumab, a rank ligand inhibitor for prevention of skeletal-related events due to bone metastases from solid tumors in adultsGail M Wilkes
Clinical Journal of Oncology Nursing|May 10, 2002
New therapeutic options in colon cancer: focus on oxaliplatinGail M Wilkes
Clinical Journal of Oncology Nursing|March 9, 2005
Therapeutic options in the management of colon cancer: 2005 updateGail M Wilkes
Oncology (Williston Park, N.Y.)|October 28, 2009
Drug essentials. Small molecule multitargeted TKI therapyGail M Wilkes
Pageof 2